Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine – Saglik Bilimleri University, Turkey

Dr. Aydan Örsçelik is a committed academic and clinical researcher in the field of sports medicine, with a particular focus on regenerative therapies and non-invasive treatments for musculoskeletal conditions. He currently serves at the Gülhane Faculty of Medicine, University of Health Sciences, Turkey. Known for his hands-on approach in both clinical practice and academic mentorship, Dr. Örsçelik’s work bridges the gap between research and patient care. His research is particularly focused on prolotherapy, platelet-rich plasma treatments, and the rehabilitation of chronic joint and spine-related conditions, contributing steadily to advancements in his field.

Profile:

Orcid | Scopus | Google Scholar

Education:

Dr. Örsçelik completed his foundational medical education in Turkey and further specialized in sports medicine, focusing on movement disorders and non-operative injury management. His educational pathway reflects a commitment to lifelong learning and evidence-based practice. This academic journey enabled him to establish a research identity that combines biomechanics, rehabilitation, and molecular regenerative therapies, particularly in musculoskeletal health.

Experience:

Over the years, Dr. Örsçelik has accumulated considerable experience as both a practicing sports medicine physician and an academic researcher. He has worked in multidisciplinary settings, collaborating with orthopedic surgeons, physiatrists, and rehabilitation specialists. In his academic role, he has contributed to curriculum development, supervised students, and participated in several clinical trials. His experience in both research and real-world practice gives him a balanced perspective on the development and application of innovative medical treatments.

Research Interests:

Dr. Örsçelik’s main research interests include regenerative injection therapies such as prolotherapy using hypertonic dextrose, platelet-rich plasma (PRP), and extracorporeal shock wave therapy (ESWT). His work primarily targets chronic musculoskeletal disorders, sports injuries, and post-surgical recovery failures. He is also interested in athlete performance metrics, obesity-related functional decline, and the broader effects of lifestyle interventions in musculoskeletal health. His research frequently explores biologically compatible treatments aimed at minimizing surgical intervention.

Awards & Recognition:

While formal awards are not explicitly listed, Dr. Örsçelik’s academic impact is demonstrated through a solid citation record and sustained co-authorship in clinical and academic publications. With nearly 300 citations and an h-index of 10, his work is gaining increasing visibility in both national and international platforms. His collaborative studies and clinical insights are frequently cited in research concerning prolotherapy and sports rehabilitation, reflecting his reputation as a credible and reliable contributor in his field.

Selected Publications:

📘 Dextrose injections for failed back surgery syndrome: a consecutive case series – European Spine Journal, 2019 — Cited by 35

🧪 Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apoptotic factors – Gülhane Medical Journal, 2018 — Cited by 29

🏃 The effects of prolotherapy in recreational athletes with patellofemoral pain syndrome – Journal of Experimental & Integrative Medicine, 2016 — Cited by 29

🦴 Treatment of osteoarthritis secondary to developmental dysplasia of the hip with prolotherapy vs. exercise control – Medical Science Monitor, 2020 — Cited by 19

💥 The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia – Medical Principles and Practice, 2020 — Cited by 17

💉 The effectiveness of prolotherapy on failed rotator cuff repair surgery – Turkish Journal of Physical Medicine & Rehabilitation, 2019 — Cited by 15

🧍 Is 5% dextrose prolotherapy effective for radicular low back pain? – Gülhane Tıp Dergisi, 2019 — Cited by 14

Conclusion:

Dr. Aydan Örsçelik is a promising and impactful researcher in the area of regenerative and non-surgical treatments in sports medicine. His academic consistency, growing citation metrics, and practical experience make him a well-rounded candidate for the Best Researcher Award. Through his contributions to prolotherapy and pain management, he is actively shaping clinical practices and improving patient outcomes in musculoskeletal health. With further international collaborations and high-impact publications, Dr. Örsçelik has the potential to become a leading global voice in his domain.

 

 

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5